Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00201877. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00553501. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01035463. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02303392. IPD Sharing: NO. Countries: 1. Publications: 1.
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT01118026. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT01508312. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00262860. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma
ClinicalTrials.gov study NCT01182415. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02432235. IPD Sharing: NO. Countries: 2. Publications: 3.
Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01995669. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT00540007. IPD Sharing: NO. Countries: 1. Publications: 2.
Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study
ClinicalTrials.gov study NCT03517137. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
ClinicalTrials.gov study NCT01874054. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01336933. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2
ClinicalTrials.gov study NCT01724021. IPD Sharing: Not stated. Countries: 32. Publications: 2.
Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)
ClinicalTrials.gov study NCT00329030. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT01282424. IPD Sharing: YES. Countries: 6. Publications: 3.
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
ClinicalTrials.gov study NCT00238238. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
ClinicalTrials.gov study NCT03744676. IPD Sharing: YES. Countries: 1. Publications: 2.
BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00088530. IPD Sharing: Not stated. Countries: 20. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.